B.Sc. (Greece). M.Sc.(London, UK). Ph.D (Toronto). MD (Toronto), FRCPC
Associate Professor, McMaster University
Department of Oncology - Division of Radiation Oncology
P: 905-387-9495 Ext. 64704
Juravinski Cancer Centre
3rd Floor Room 3-205H
699 Concession Street
Hamilton Ontario, L8V 5C2
Areas of Interest
Dr. Tsakiridis' research interests include; cancer and radiation biology studies aiming to understand the mechanisms of tumor cell resistance to cytotoxic therapy with radiation and chemotherapy. Translational pre-clinical studies of signaling inhibitors and targeted therapy agents in combination with radiation.
- Sanli T, Storozhuk Y, Linher-Melville K, Bristow RG, Laderout K, Viollet B, Wright J, Singh G, Tsakiridis T. Ionizing radiation regulates the expression of AMP-activated protein kinase (AMPK) in epithelial cancer cells: modulation of cellular signals regulating cell cycle and survival. Radiother Oncol. 2012 Mar;102(3):459-65.
- Sanli T, Rashid A, Liu C, Harding S, Bristow RG, Cutz JC, Singh G, Wright J, Tsakiridis T. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int J Radiat Oncol Biol Phys. 2010
- Tsakiridis T, Cutz JC, Singh G, Hirte H, Okawara G, Corbett T, Sur R, Cai W, Whelan T, Wright JR. Association of phosphorylated epidermal growth factor receptor with survival in patients with locally advanced non-small cell lung cancer treated with radiotherapy. J Thorac Oncol. 2008 Jul;3(7):716-22.
Search for citations for Dr. Tsakiridis on PubMed